These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37031718)

  • 1. Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals.
    Kushner T; Lange M; Argiriadi PA; Meislin R; Sigel K; Terrault N;
    Clin Gastroenterol Hepatol; 2024 Jan; 22(1):194-196.e1. PubMed ID: 37031718
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications.
    Andronescu CI; Purcarea MR; Babes PA
    J Med Life; 2018; 11(1):20-23. PubMed ID: 29696060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.
    Paik J; Golabi P; Younoszai Z; Mishra A; Trimble G; Younossi ZM
    Liver Int; 2019 Feb; 39(2):342-352. PubMed ID: 30347513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease.
    Diehl AM; Farpour-Lambert NJ; Zhao L; Tilg H
    Nat Metab; 2019 Nov; 1(11):1027-1029. PubMed ID: 32694863
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease].
    Xing A; Ji C; Shi J; Du X; Huang Z; Lin L; Xiong H; Wu S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jan; 36(1):40-4. PubMed ID: 25876863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mexican consensus on nonalcoholic fatty liver disease.
    Bernal-Reyes R; Castro-Narro G; Malé-Velázquez R; Carmona-Sánchez R; González-Huezo MS; García-Juárez I; Chávez-Tapia N; Aguilar-Salinas C; Aiza-Haddad I; Ballesteros-Amozurrutia MA; Bosques-Padilla F; Castillo-Barradas M; Chávez-Barrera JA; Cisneros-Garza L; Flores-Calderón J; García-Compeán D; Gutiérrez-Grobe Y; Higuera de la Tijera MF; Kershenobich-Stalnikowitz D; Ladrón de Guevara-Cetina L; Lizardi-Cervera J; López-Cossio JA; Martínez-Vázquez S; Márquez-Guillén E; Méndez-Sánchez N; Moreno-Alcantar R; Poo-Ramírez JL; Ramos-Martínez P; Rodríguez-Hernández H; Sánchez-Ávila JF; Stoopen-Rometti M; Torre-Delgadillo A; Torres-Villalobos G; Trejo-Estrada R; Uribe-Esquivel M; Velarde-Ruiz Velasco JA
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):69-99. PubMed ID: 30711302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
    Zawdie B; Tadesse S; Wolide AD; Nigatu TA; Bobasa EM
    Ethiop J Health Sci; 2018 Jan; 28(1):19-30. PubMed ID: 29622904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderation Effect of Handgrip Strength on the Associations of Obesity and Metabolic Syndrome With Fatty Liver in Adolescents.
    Lee K
    J Clin Densitom; 2020; 23(2):278-285. PubMed ID: 31060787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.
    Rinella M; Charlton M
    Hepatology; 2016 Jul; 64(1):19-22. PubMed ID: 26926530
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and Impact of Fatty Liver Disease in Adult Deceased Liver Transplant Donors: Metabolic-Associated Fatty Liver Disease or Nonalcoholic Fatty Liver Disease?
    Liu K; Pandya K; West C; Virtue S; McCaughan GW
    Liver Transpl; 2021 Oct; 27(10):1498-1501. PubMed ID: 33599378
    [No Abstract]   [Full Text] [Related]  

  • 12. Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes.
    Lonardo A; Byrne CD; Caldwell SH; Cortez-Pinto H; Targher G
    Hepatology; 2016 Oct; 64(4):1388-9. PubMed ID: 27038241
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
    Sayiner M; Koenig A; Henry L; Younossi ZM
    Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.
    Araújo AR; Rosso N; Bedogni G; Tiribelli C; Bellentani S
    Liver Int; 2018 Feb; 38 Suppl 1():47-51. PubMed ID: 29427488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence and harm of nonalcoholic fatty liver disease].
    Shao YL; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):10-13. PubMed ID: 30685917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
    Nabi O; Lacombe K; Boursier J; Mathurin P; Zins M; Serfaty L
    Gastroenterology; 2020 Aug; 159(2):791-793.e2. PubMed ID: 32376412
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease.
    Lao TT
    Best Pract Res Clin Obstet Gynaecol; 2020 Oct; 68():2-11. PubMed ID: 32312689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.